Martin Shkreli is stuck with an injunction barring him from the industry that spawned his “Pharma Bro” nickname after he failed Monday to convince a federal judge in New York to put the ban on hold while he appeals.
Shkreli, the former CEO of Vyera Pharmaceuticals LLC who’s currently serving time in federal prison for securities fraud, didn’t show that a stay—or modification—of the injunction was warranted, the U.S. District Court for the Southern District of New York said.
“With few exceptions, his motion relies upon prior arguments that have been considered and rejected, or on a crimped reading ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.